17 June 2019

Kuros Biosciences AG (Kuros) entered into a convertible bond financing agreement with Nice & Green SA for up to a maximum of CHF 5 million. The facility is provided by Nice & Green SA (N&G), a private Swiss company which specializes in financing solutions tailored to the requirements of listed growth companies in the biotech and cleantech industries. The facility enables Kuros to draw 12 equal tranches representing 100,000 shares each over 12 months against issuance of convertible bonds. The convertible bonds are convertible into equity at the discretion of N&G within a period of 12 months after their issuance, with a conversion rate of 95% of the lowest volume-weighted average price during the six trading days preceding the conversion date. The agreement can be extended by Kuros for an additional CHF 5 million over a further period of 12 months. VISCHER AG advised Kuros with Matthias Staehelin (Partner, Corporate) and Angelo Imperiale (Associate, Corporate).

Kuros press release

Categories: Employment Law, Banking & Finance, Data & Privacy, Corporate and Commercial, Life Sciences, Pharma, Biotech

You are currently offline. Some pages or content may fail to load.